Institute of Cancer Research

(Newser) - A new experimental pill taken once a day is proving effective against an advanced, aggressive form of prostate cancer which has resisted other therapies, reports Reuters. The drug, abiraterone, created by Cougar Biotechnology, significantly shrank tumors in a clinical trial, according to a study in the Journal of Clinical Oncology....

(Newser) - British scientists have identified the stem cells that cause the most common type of childhood leukemia, the Times of London reports. The unprecedented discovery means doctors can monitor cell levels in young cancer patients and stop treatment when those cells are gone, said a leading oncology expert. The work also...